| Never-smokers (57 cases, 146 controls) | Ever-smokers (50 cases, 108 controls) | p for heterogeneity | ||
---|---|---|---|---|---|
 | cases/controls | OR (95% CI) * †| cases/controls | OR (95% CI) |  |
GSTM1 null | 33/70 | 1.55 (0.83–2.90) | 26/64 | 0.70 (0.35–1.39) | 0.10 |
GSTT1 null | 21/34 | 2.09 (1.06–4.11) | 18/23 | 2.17 (1.02–4.59) | 0.92 |
CYP1A1*2A | 14/33 | 1.09 (0.53–2.27) | 8/23 | 0.66 (0.27–1.61) | 0.40 |
CYP2E1*5 | 4/11 | 0.86 (0.26–2.88) | 1/9 | 0.20 (0.02–2.70) | 0.24 |
CYP2E1*5A or *6 | 10/17 | 1.59 (0.67–3.79) | 5/10 | 0.99 (0.31–3.13) | 0.58 |
NAT2 Slow ‡ | 34/77 | 1.39 (0.74–2.60) | 30/54 | 1.50 (0.75–2.98) | 0.87 |
SULT1A1 His carriers | 22/62 | 0.86 (0.45–1.64) | 27/36 | 2.58 (1.27–5.25) | 0.03 |
EPHX1 exon 3 His carriers | 28/62 | 1.31 (0.70–2.46) | 28/56 | 1.12 (0.57–2.22) | 0.69 |
EPHX4 exon 4 Arg carriers | 21/63 | 0.84 (0.44–1.60) | 16/38 | 0.89 (0.43–1.85) | 0.85 |
 | Never-drinkers (32 cases, 121 controls) | Ever-drinkers (73 cases, 133 controls) | p for heterogeneity | ||
 | cases/controls | OR (95% CI) | cases/controls | OR (95% CI) |  |
GSTM1 null | 16/64 | 0.95 (0.43–2.10) | 43/70 | 1.23 (0.69–2.20) | 0.55 |
GSTT1 null | 13/24 | 3.15 (1.32–7.47) | 26/33 | 1.72 (0.92–3.22) | 0.27 |
CYP2E1*5 | 0/10 | - | 5/10 | 0.86 (0.28–2.68) | - |
CYP2E1*5A or *6 | 1/19 | 0.18 (0.22–1.46) | 14/8 | 3.70 (1.45–9.37) | 0.001 |
SULT1A1 His carriers | 16/51 | 1.42 (0.63–3.17) | 33/47 | 1.56 (0.86–2.82) | 0.98 |